Literature DB >> 24050258

Mitochondrial protein acetylation as a cell-intrinsic, evolutionary driver of fat storage: chemical and metabolic logic of acetyl-lysine modifications.

Sirisha Ghanta1, Ruth E Grossmann, Charles Brenner.   

Abstract

Hormone systems evolved over 500 million years of animal natural history to motivate feeding behavior and convert excess calories to fat. These systems produced vertebrates, including humans, who are famine-resistant but sensitive to obesity in environments of persistent overnutrition. We looked for cell-intrinsic metabolic features, which might have been subject to an evolutionary drive favoring lipogenesis. Mitochondrial protein acetylation appears to be such a system. Because mitochondrial acetyl-coA is the central mediator of fuel oxidation and is saturable, this metabolite is postulated to be the fundamental indicator of energy excess, which imprints a memory of nutritional imbalances by covalent modification. Fungal and invertebrate mitochondria have highly acetylated mitochondrial proteomes without an apparent mitochondrially targeted protein lysine acetyltransferase. Thus, mitochondrial acetylation is hypothesized to have evolved as a nonenzymatic phenomenon. Because the pKa of a nonperturbed Lys is 10.4 and linkage of a carbonyl carbon to an ε amino group cannot be formed with a protonated Lys, we hypothesize that acetylation occurs on residues with depressed pKa values, accounting for the propensity of acetylation to hit active sites and suggesting that regulatory Lys residues may have been under selective pressure to avoid or attract acetylation throughout animal evolution. In addition, a shortage of mitochondrial oxaloacetate under ketotic conditions can explain why macronutrient insufficiency also produces mitochondrial hyperacetylation. Reduced mitochondrial activity during times of overnutrition and undernutrition would improve fitness by virtue of resource conservation. Micronutrient insufficiency is predicted to exacerbate mitochondrial hyperacetylation. Nicotinamide riboside and Sirt3 activity are predicted to relieve mitochondrial inhibition.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24050258      PMCID: PMC4113336          DOI: 10.3109/10409238.2013.838204

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  62 in total

Review 1.  Adenosine monophosphate-activated protein kinase: a central regulator of metabolism with roles in diabetes, cancer, and viral infection.

Authors:  D G Hardie
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-11-09

2.  Identification of a molecular component of the mitochondrial acetyltransferase programme: a novel role for GCN5L1.

Authors:  Iain Scott; Bradley R Webster; Jian H Li; Michael N Sack
Journal:  Biochem J       Date:  2012-05-01       Impact factor: 3.857

3.  The yeast mitochondrial carrier Leu5p and its human homologue Graves' disease protein are required for accumulation of coenzyme A in the matrix.

Authors:  C Prohl; W Pelzer; K Diekert; H Kmita; T Bedekovics; G Kispal; R Lill
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 4.  The glucose-alanine cycle.

Authors:  P Felig
Journal:  Metabolism       Date:  1973-02       Impact factor: 8.694

5.  SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production.

Authors:  Tadahiro Shimazu; Matthew D Hirschey; Lan Hua; Kristin E Dittenhafer-Reed; Bjoern Schwer; David B Lombard; Yu Li; Jakob Bunkenborg; Frederick W Alt; John M Denu; Matthew P Jacobson; Eric Verdin
Journal:  Cell Metab       Date:  2010-12-01       Impact factor: 27.287

6.  Large shifts in pKa values of lysine residues buried inside a protein.

Authors:  Daniel G Isom; Carlos A Castañeda; Brian R Cannon; Bertrand García-Moreno
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-09       Impact factor: 11.205

7.  Reversibility of the mitochondrial isocitrate dehydrogenase reaction in the perfused rat liver. Evidence from isotopomer analysis of citric acid cycle intermediates.

Authors:  C Des Rosiers; C A Fernandez; F David; H Brunengraber
Journal:  J Biol Chem       Date:  1994-11-04       Impact factor: 5.157

Review 8.  Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition.

Authors:  Katrina L Bogan; Charles Brenner
Journal:  Annu Rev Nutr       Date:  2008       Impact factor: 11.848

9.  A mitochondrial protein compendium elucidates complex I disease biology.

Authors:  David J Pagliarini; Sarah E Calvo; Betty Chang; Sunil A Sheth; Scott B Vafai; Shao-En Ong; Geoffrey A Walford; Canny Sugiana; Avihu Boneh; William K Chen; David E Hill; Marc Vidal; James G Evans; David R Thorburn; Steven A Carr; Vamsi K Mootha
Journal:  Cell       Date:  2008-07-11       Impact factor: 41.582

10.  Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase.

Authors:  Jintang Du; Yeyun Zhou; Xiaoyang Su; Jiu Jiu Yu; Saba Khan; Hong Jiang; Jungwoo Kim; Jimin Woo; Jun Huyn Kim; Brian Hyun Choi; Bin He; Wei Chen; Sheng Zhang; Richard A Cerione; Johan Auwerx; Quan Hao; Hening Lin
Journal:  Science       Date:  2011-11-11       Impact factor: 47.728

View more
  40 in total

1.  The Acetyl Group Buffering Action of Carnitine Acetyltransferase Offsets Macronutrient-Induced Lysine Acetylation of Mitochondrial Proteins.

Authors:  Michael N Davies; Lilja Kjalarsdottir; J Will Thompson; Laura G Dubois; Robert D Stevens; Olga R Ilkayeva; M Julia Brosnan; Timothy P Rolph; Paul A Grimsrud; Deborah M Muoio
Journal:  Cell Rep       Date:  2015-12-31       Impact factor: 9.423

2.  Lysine Acetylation Activates Mitochondrial Aconitase in the Heart.

Authors:  Jolyn Fernandes; Alexis Weddle; Caroline S Kinter; Kenneth M Humphries; Timothy Mather; Luke I Szweda; Michael Kinter
Journal:  Biochemistry       Date:  2015-06-19       Impact factor: 3.162

3.  Metabolism: Targeting a fat-accumulation gene.

Authors:  Charles Brenner
Journal:  Nature       Date:  2014-04-10       Impact factor: 49.962

4.  Crosstalk Between Mitochondrial Hyperacetylation and Oxidative Stress in Vascular Dysfunction and Hypertension.

Authors:  Sergey I Dikalov; Anna E Dikalova
Journal:  Antioxid Redox Signal       Date:  2019-02-28       Impact factor: 8.401

5.  Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy.

Authors:  Nicolas Diguet; Samuel A J Trammell; Cynthia Tannous; Robin Deloux; Jérôme Piquereau; Nathalie Mougenot; Anne Gouge; Mélanie Gressette; Boris Manoury; Jocelyne Blanc; Marie Breton; Jean-François Decaux; Gareth G Lavery; István Baczkó; Joffrey Zoll; Anne Garnier; Zhenlin Li; Charles Brenner; Mathias Mericskay
Journal:  Circulation       Date:  2017-12-07       Impact factor: 29.690

6.  Tricarboxylic acid cycle activity suppresses acetylation of mitochondrial proteins during early embryonic development in Caenorhabditis elegans.

Authors:  Kazumasa Hada; Keiko Hirota; Ai Inanobe; Koichiro Kako; Mai Miyata; Sho Araoi; Masaki Matsumoto; Reiya Ohta; Mitsuhiro Arisawa; Hiroaki Daitoku; Toshikatsu Hanada; Akiyoshi Fukamizu
Journal:  J Biol Chem       Date:  2019-01-03       Impact factor: 5.157

Review 7.  Regulation of autophagy and mitophagy by nutrient availability and acetylation.

Authors:  Bradley R Webster; Iain Scott; Javier Traba; Kim Han; Michael N Sack
Journal:  Biochim Biophys Acta       Date:  2014-02-11

8.  Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock.

Authors:  Deborah M Muoio
Journal:  Cell       Date:  2014-12-04       Impact factor: 41.582

Review 9.  Chemical and Physiological Features of Mitochondrial Acylation.

Authors:  Alison E Ringel; Sarah A Tucker; Marcia C Haigis
Journal:  Mol Cell       Date:  2018-11-15       Impact factor: 17.970

Review 10.  The growing landscape of lysine acetylation links metabolism and cell signalling.

Authors:  Chunaram Choudhary; Brian T Weinert; Yuya Nishida; Eric Verdin; Matthias Mann
Journal:  Nat Rev Mol Cell Biol       Date:  2014-08       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.